FOOTPATH: A randomized, open-label phase-2 study of liposomal irinotecan + 5-FU and folinic acid (NAPOLI) versus sequential NAPOLI and mFOLFOX6 versus gemcitabine/nab-paclitaxel in treatment-naive metastatic pancreatic cancer (mPDAC).
5-FU;Folinic Acid;Liposomal Irinotecan;5-FU;Folinic Acid;Gemcitabine;Liposomal Irinotecan;mFOLFOX6;Nab-Paclitaxel
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: FOOTPATH: A randomized, open-label phase-2 study of liposomal irinotecan + 5-FU and folinic acid (NAPOLI) versus sequential NAPOLI and mFOLFOX6 versus gemcitabine/nab-paclitaxel in treatment-naive metastatic pancreatic cancer (mPDAC). ### Output: 5-FU;Folinic Acid;Liposomal Irinotecan;5-FU;Folinic Acid;Gemcitabine;Liposomal Irinotecan;mFOLFOX6;Nab-Paclitaxel